Fecal Incontinence Clinical Trial
Official title:
The Impact of Fiber Fermentation on Fecal Incontinence
| Verified date | May 2023 |
| Source | University of Minnesota |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The primary aim of this study was to compare the effects of supplementation with one of three dietary fibers (gum arabic, carboxy-methylcellulose, or psyllium) or a placebo on fecal incontinence (FI), symptom intolerance, and quality of life in community-living individuals who have incontinence of loose or liquid feces. A secondary aim was to explore the possible mechanism(s) underlying the supplements' efficacy (i.e., improvements in stool consistency, water-holding capacity or gel formation).
| Status | Completed |
| Enrollment | 206 |
| Est. completion date | December 2010 |
| Est. primary completion date | June 2007 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - age =18 years - living in the community (not a nursing home or assisted living facility) - self-report of usually having FI of loose or liquid consistency at least twice in a 2-wk period - toilets independently - ability to read and write in English. - Persons that regularly performed pelvic floor muscle exercises and/or biofeedback on a maintenance regimen for at least 20 wks or who took a steady dose of anti-motility medications on a regular schedule that still met the FI criteria were also eligible. Exclusion Criteria: - difficulty swallowing, - a gastrointestinal (GI) tract altered by surgery, - a malabsorption disorder, - inflammatory bowel disease, - gastrointestinal cancer or active cancer treatment, - allergy to the fibers, - regularly used a laxative or enema, were tube-fed, or unwilling to discontinue taking periodic self-prescribed fiber supplements or anti-diarrheal medications. - a score =24 on the Mini Mental State Examination - having/reporting fewer than two episodes of FI or being incapable of performing study procedures during the run-in baseline period |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Minnesota | Minneapolis | Minnesota |
| Lead Sponsor | Collaborator |
|---|---|
| University of Minnesota |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | self-reported rating of consistency of continent stools on a daily stool diary | the Stool Consistency Classification System used was shown to be valid and reliable | ||
| Other | usual diet intake | written record of all food and drink consumed | ||
| Other | report of additional fluid intake | subjects checked whether the drank required amount of additional fluid and wrote the date and time of drinking | ||
| Other | absorbent pad soiling | subjects indicated number of absorbent products that were soiled on stool diary and and saved and returned them to be assessed by study team | ||
| Other | self-report of any stools not collected | reported on stool diary daily with reason for not collecting | ||
| Other | Stool Color change | date and time a stool color change was observed after swallowing a capsule with a decoy or marker dose of a food dye; date and time capsule was taken was also reported | ||
| Other | in vitro fiber degradation | nested experiment of in vitro degradation of each dietary fiber by stools of subjects using established procedure reported in Bliss, D.Z. et al. Nurs. Res. 2001, 50, 203-213. | ||
| Other | total dietary fiber content of fiber sources used in Study | established method of Theander O. et al. J AOAC Int. 1995;78(4):1030-44 used. | ||
| Other | Personal Goals of Treatment for Fecal Incontinence and Satisfaction with Achievement of Goals | data obtained by semi-structured interview | ||
| Other | modifications of preparation of foods, diet intake, and eating pattern to manage fecal incontinence | data obtained by semi-structured interview | ||
| Primary | self-report of an incontinent episode on a daily stool diary | the date and time of an incontinence episode was reported and the ratio of the number of incontinence episodes to total stools daily was calculated | ||
| Secondary | self-report of gastro-intestinal symptoms on a daily symptom record | The amount of GI symptoms reported were flatus, belching, bloating, abdominal cramping, nausea, a feeling of fullness, and stomach upset using a categorical scale. Number of times of flatus was also reported.
The amount of two obfuscating symptoms were also reported. headache and sleepiness. How upsetting/bothersome the symptoms were were also reported. |
||
| Secondary | self-report of quality of life | The Fecal Incontinence Quality of Life tool (FIQL) was used; Rockwood, T.H. et al. Diseases of the Colon & Rectum. 2000;43(1):9-16. | ||
| Secondary | Water-holding capacity of non-frozen of stools | Measure was done on stools of 52 randomly selected subjects (13 from each group) Established method of Wenzl, H. et al. Gastroenterology. 1995;108(6):1729-38 used. | ||
| Secondary | Gel formation of non-frozen stools | Measure was done on stools of 52 randomly selected subjects (13 from each group); Established method of Fischer, M.H. et al.Carbohydrate Research 2004;339(11): 2009-2017. | ||
| Secondary | Total dietary fiber content of feces | Measured in composites of all stools from baseline and supplement periods and non-frozen stools
Established method of Theander O, et al. J AOAC Int. 1995;78(4):1030-44 used. |
||
| Secondary | Self-report of amount of supplement consumed | reported by fractions on supplement intake form and return of unconsumed portion was assessed by study team | ||
| Secondary | amount of fecal incontinence | subjects self-reported greatest amount of soiling (from soling of tissue between buttocks to shoes or floor) | ||
| Secondary | wet and dry weights of collected stools and percentage of water content | collected stools were weighed and freeze-dried to constant weight; percentage of water content was calculated from these values |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03825575 -
Sacral Neuromodulation as Treatment for Fecal Incontinence
|
N/A | |
| Completed |
NCT00605826 -
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
|
N/A | |
| Withdrawn |
NCT02208258 -
Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.
|
N/A | |
| Completed |
NCT01939821 -
A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes
|
N/A | |
| Completed |
NCT01957969 -
French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence
|
N/A | |
| Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
| Recruiting |
NCT00530933 -
Tibial Nerve Stimulation for Faecal Incontinence
|
N/A | |
| Completed |
NCT00565136 -
Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00522691 -
Efficacy of Sacral Nerve Stimulation Before Definitive Implantation
|
N/A | |
| Completed |
NCT00677508 -
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
|
||
| Completed |
NCT05032534 -
Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence
|
N/A | |
| Completed |
NCT05058326 -
Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
|
||
| Completed |
NCT03746834 -
NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation
|
Phase 4 | |
| Completed |
NCT00124904 -
Biofeedback for Fecal Incontinence
|
N/A | |
| Completed |
NCT03028636 -
LIBERATE - PRO: Eclipseâ„¢ System Registry
|
||
| Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 | |
| Completed |
NCT05621629 -
Management of FI After Surgery of ARM
|
||
| Withdrawn |
NCT04138602 -
BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence
|
N/A | |
| Completed |
NCT03252951 -
Physical Therapy for Anal Incontinence
|
N/A | |
| Completed |
NCT04478799 -
Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience
|
N/A |